This article was originally published in The Gray Sheet
Executive SummaryOrthopedic firm gains access to the spinal implant market via an exclusive three-year U.S. distribution agreement with Paris-based spinal implant maker Scient'x, Encore reports Oct. 30. FDA clearance for the firm's Isolock-Isobar rigid fixation system is expected in "early 1999." Other offerings from Scient'x needing a nod from FDA include the PCB cervical plate system for anterior fusion of the cervical spine and the Isomorphic lumbar cage system
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.